A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. - Related Studies

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.

This study has been completed.

Study NCT00236795. Last updated on May 11, 2007. Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Female Contraception
		Contraception

2	Additional drug interventions recognized in this trial
		Estradiol
		Estradiol 17 beta-cypionate
		Estradiol 3-benzoate
		Estradiol valerate
		Ethinyl Estradiol
		Ethinyl Estradiol-Norgestrel Combination
		Norelgestromin
		Polyestradiol phosphate

3	More general drug interventions related to this trial
		Contraceptive Agents
		Contraceptive Agents, Female
		Contraceptives, Oral
		Contraceptives, Oral, Combined
		Contraceptives, Oral, Synthetic
		Contraceptives, Postcoital
		Contraceptives, Postcoital, Synthetic
		Estrogens
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

4	Sponsors listed in this trial
		Johnson &Johnson Pharmaceutical Research &Development, L.L.C.